An editorial by T.C. Theoharides in Clinical Therapeutics (June 2018) highlighting health hazards from mold and mycotoxins—particularly after flooding—contrasting systemic fungal infections (mycoses) with more common mold-related exposures and their varied symptoms. The piece notes rising fungal threats tied to climate change, difficulties in diagnosis because symptoms overlap with other syndromes, public-health guidance from CDC/NIH, and references several articles in the same journal issue addressing aspergillosis, mucormycoses, immune responses to fungi, clinical case series, and neuroimmune effects of mycotoxins.
Questions this document answers
Clinical Therapeutics, Volume 40, Number 6, June 2018
Theoharis C. Theoharides, Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Immunology, Tufts University School of Medicine, Tufts University, Boston, Massachusetts
About 15% of the workforce (and about as many schoolchildren).
10.1016/j.clinthera.2018.05.005